Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × avapritinib × Gastrointestinal × Clear all

Status

Completed 5 Recruiting 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1 CNS 1

Conditions

Glioma 1 Gastrointestinal Stromal Tumors 1

Interventions

regorafenib 2 zanidatamab 1 peginterferon alfa-2a 1 pegilodecakin 1 onvansertib 1 omburtamab I-131 1 guselkumab 1 derazantinib 1 avapritinib 1 Tenofovir 1 Melphalan 1 IMM-101 1 IFL protocol 1 HMPL-013 1 Everolimus 1 Brachytherapy 1 Bevacizumab 1 AM0010 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04714086 2024-10-24

Expanded Access Program for Avapritinib

Blueprint Medicines Corporation

No longer available

CNSGastrointestinalSarcoma

Glioma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡